Nordion Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Nordion Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Nordion (or ‘the company’) is a provider of products and services needed for the development of drugs, diagnosis and treatment of diseases. It also offers pharmaceutical research services, medical isotopes for molecular imaging, sterilization, radiotherapeutics and analytical instruments. The company is headquartered in Ontario, Canada, and employed about 500 people as of October 31, 2011. The company recorded revenues of $274 million during the financial year ended October 2011 (FY2011), an increase of 23.5% over FY2010. The operating profit of the company was $53 million during FY2011, as compared to an operating loss of $86 million in FY2010. The net profit was $16.8 million in FY2011, as compared to a net loss of $232 million in FY2010.
Scope of the Report
Provides all the crucial information on Nordion Inc. required for business and competitor intelligence needs
Contains a study of the major internal and external factors affecting Nordion Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Nordion Inc.
Data is supplemented with details on Nordion Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Nordion Inc.
Reasons to Purchase
Support sales activities by understanding your customers’ businesses better
Understand prospective partners and suppliers
Keep fully up to date on your competitors’ business structure, strategy and prospects
Obtain the most up to date company information available